Testing of some pharmacological characteristics of the autochthonous product Acyclovir.

Romanian journal of virology Pub Date : 1995-01-01
A Muţiu, O Belu, D Rojanschi, M Petica, I Crişan, V Vasilioni, C Fodor
{"title":"Testing of some pharmacological characteristics of the autochthonous product Acyclovir.","authors":"A Muţiu,&nbsp;O Belu,&nbsp;D Rojanschi,&nbsp;M Petica,&nbsp;I Crişan,&nbsp;V Vasilioni,&nbsp;C Fodor","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In the present work, the preliminary results of a study regarding the pharmacokinetic properties of the autochthonous synthetic drug Acyclovir are shown. The in vitro and in vivo toxicologic test demonstrates a low toxicity of this product, the drug being well tolerated both by the laboratory animal and by the fibroblasts of the human embryo. The specific antiviral action of the product on the multiplication in vitro of the Herpes simplex virus types 1 and 2, appreciated by the lowering capacity of the infection titre and by the determination of the inhibitory concentration 50% (IC50), is significant and comparable with previous results obtained by the authors by testing the drug Zovirax of the Welcome firm.</p>","PeriodicalId":79532,"journal":{"name":"Romanian journal of virology","volume":"46 1-2","pages":"9-19"},"PeriodicalIF":0.0000,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Romanian journal of virology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In the present work, the preliminary results of a study regarding the pharmacokinetic properties of the autochthonous synthetic drug Acyclovir are shown. The in vitro and in vivo toxicologic test demonstrates a low toxicity of this product, the drug being well tolerated both by the laboratory animal and by the fibroblasts of the human embryo. The specific antiviral action of the product on the multiplication in vitro of the Herpes simplex virus types 1 and 2, appreciated by the lowering capacity of the infection titre and by the determination of the inhibitory concentration 50% (IC50), is significant and comparable with previous results obtained by the authors by testing the drug Zovirax of the Welcome firm.

本土产品阿昔洛韦的一些药理学特性试验。
在目前的工作中,显示了关于本土合成药物阿昔洛韦的药代动力学性质的初步研究结果。体外和体内毒理学试验表明该产品毒性低,实验动物和人类胚胎成纤维细胞对该药物均有良好的耐受性。通过降低感染滴度和抑制浓度50% (IC50)的测定,该产品对1型和2型单纯疱疹病毒体外增殖的特异性抗病毒作用是显著的,与作者先前通过测试Welcome公司的药物Zovirax获得的结果相当。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信